Latest news
Loading news…
Zymeworks
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Vancouver, British Columbia, Canada Founded 2004 101-250 employees For Profit
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
2
Monthly Visits
Available in Pro Contacts
267
Ticker
ZYME
NYSE - New York Stock Exchange
Patents
176
13 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ZYME
- Exchange
- NYSE - New York Stock Exchange
- IPO date
- Apr 27, 2017
- Raised at IPO
- $64M
- Valuation at IPO
- $324M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 24
- Active products
- 29
- Patents granted
- 176
- Trademarks
- 13
- Top patent class
- Organic Chemistry
- IT spend
- $3M
Company Info
- Founded
- 2004
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 438
- HQ
- Vancouver, British Columbia, Canada
- Exit date
- Apr 27, 2017
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 7.1
- Trend (90d)
- 4.3
- Last leadership hire
- Apr 1, 2026
- Last layoff mention
- Jan 21, 2022
Acquisitions by Zymeworks
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Zymeworks
Chair & Chief Executive Officer
Chairman
Executive Vice President, Head of Research and Development
Executive Vice President, Chief Financial Officer
Associate Director, Oncology
Chief Scientific Officer
Executive Vice President, Chief Business Officer
Senior Director, Business Development & Alliance Management
267
professional contacts at Zymeworks
Contact execs at Zymeworks →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Zymeworks
Loading news…
FAQs about Zymeworks
People who checked this page also checked these
Sectors Zymeworks invests & acquires in
Browse the full Acquirezy directory.